Life Sciences
February 9, 2001
Andrew Harkin, Thomas J. Connor, J Mulrooney et al.
The substituted amphetamine 3,4 methylenedioxyamphetamine (MDA) is a popular recreational drug of abuse. Administration of MDA to experimental animals has been shown to induce damage to serotonergic axons and nerve terminals. However, there is a lack of information on whether these treatments can produce any long-term changes in behavioural performance particularly under stressful conditions....
Pharmacology & Toxicology
May 1, 1997
Ivone de Souza, John R. Kelly, Andrew Harkin et al.
29 citations
Abstract: This study examined some acute pharmacological and toxicological effects of 3,4 methylenedioxymethamphetamine (MDMA, “Ecstasy”) over a range of doses (20, 40, 80, 160 and 320 mg/kg orally) in adult female rats. Deaths were observed from the 40 mg/kg MDMA group onwards. Reductions in body weight change, food and water intake were found in the 80 mg/kg group, whilst food intake alone...
Pharmacology, Biochemistry, and Behavior
November 1995
Mairéad G. McNamara, J P Kelly, Brian E. Leonard
(+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"), an increasingly popular recreational drug, is known to damage brain serotonin (5-hydroxytryptamine [5-HT]) neurons, whilst also having a less pronounced effect on the dopaminergic system. Treatment with MDMA results in an increased locomotor activity, elevated basal serum corticosterone concentrations, decreased exploratory activity, and...
Human Psychopharmacology: Clinical and Experimental
September 1, 1995
Mairéad G. McNamara, John Kelly, Brian E. Leonard
17 citations
Abstract The aim of this study was to examine the effect of acute administration of (±)3,4‐methylenedioxymethamphetamine (MDMA) (20 mg/kg, i.p.) on colonic temperature, serum corticosterone and brain biogenic amine concentrations in group‐housed male and female rats and to determine if there are any gender differences in susceptibility to MDMA‐induced changes. Prior to treatment, basal colonic...